Cargando…

Efficacy and safety of immune checkpoint inhibitors in patients with advanced non–small cell lung cancer (NSCLC): a systematic literature review

BACKGROUND: Therapeutic strategies with immune checkpoint inhibitors (ICIs) counteract the immunosuppressive effects of programmed cell death protein-1 (PD-1) and ligand-1 (PD-L1). ICI treatment has emerged in first- and second-line therapy of non–small cell lung cancer (NSCLC). As immunotherapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wagner, Gernot, Stollenwerk, Hannah Karolina, Klerings, Irma, Pecherstorfer, Martin, Gartlehner, Gerald, Singer, Josef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458604/ https://www.ncbi.nlm.nih.gov/pubmed/32923134 http://dx.doi.org/10.1080/2162402X.2020.1774314

Ejemplares similares

Assessing the validity of abbreviated literature searches for rapid reviews: protocol of a non-inferiority and meta-epidemiologic study
por: Nussbaumer-Streit, Barbara, et al.
Publicado: (2016)

Characteristics and recovery methods of studies falsely excluded during literature screening—a systematic review
por: Affengruber, Lisa, et al.
Publicado: (2022)

Paracoccidioidomycosis Diagnosed in Europe—A Systematic Literature Review
por: Wagner, Gernot, et al.
Publicado: (2021)

Risk of Contrast-Associated Acute Kidney Injury in Patients Undergoing Peripheral Angiography with Carbon Dioxide Compared to Iodine-Containing Contrast Agents: A Systematic Review and Meta-Analysis
por: Wagner, Gernot, et al.
Publicado: (2022)

Combining abbreviated literature searches with single-reviewer screening: three case studies of rapid reviews
por: Affengruber, Lisa, et al.
Publicado: (2020)

Reply to letter to the editor “Lessons from COVID-19 to future evidence synthesis efforts: first living search strategy and out of date scientific publishing and indexing industry”
por: Nussbaumer-Streit, Barbara, et al.
Publicado: (2020)

Continuing education for the prevention of mild cognitive impairment and Alzheimer’s-type dementia: a systematic review and overview of systematic reviews
por: Matyas, Nina, et al.
Publicado: (2019)

Impact of timing of surgery in elderly hip fracture patients: a systematic review and meta-analysis
por: Klestil, Thomas, et al.
Publicado: (2018)

Immediate versus delayed surgery for hip fractures in the elderly patients: a protocol for a systematic review and meta-analysis
por: Klestil, Thomas, et al.
Publicado: (2017)

Quarantine alone or in combination with other public health measures to control COVID‐19: a rapid review
por: Nussbaumer-Streit, Barbara, et al.
Publicado: (2020)

Assessing the magnitude of reporting bias in trials of homeopathy: a cross-sectional study and meta-analysis
por: Gartlehner, Gerald, et al.
Publicado: (2022)

Screening for periodontal diseases by non-dental health professionals: a protocol for a systematic review and overview of reviews
por: Teufer, Birgit, et al.
Publicado: (2019)

Continuing education for the prevention of mild cognitive impairment and Alzheimer’s-type dementia: a systematic review protocol
por: Matyas, Nina, et al.
Publicado: (2017)

The performance of anthropometric tools to determine obesity: a systematic review and meta-analysis
por: Sommer, Isolde, et al.
Publicado: (2020)

Inadequate use and regulation of interventions against publication bias decreases their effectiveness: a systematic review
por: Thaler, Kylie, et al.
Publicado: (2015)

Vitamin D deficiency as a risk factor for dementia: a systematic review and meta-analysis
por: Sommer, Isolde, et al.
Publicado: (2017)

Hyperprogressive NSCLC With Two Immune-Checkpoint Inhibitors
por: Kasparian, Saro, et al.
Publicado: (2020)

Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC
por: Reuss, Joshua E., et al.
Publicado: (2021)

Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC
por: Walia, Anushka, et al.
Publicado: (2023)

Effectiveness of interventions for the remediation of lead-contaminated soil to prevent or reduce lead exposure - A systematic review
por: Dobrescu, Andreea-Iulia, et al.
Publicado: (2022)

Desensitizing Effect of Cancer Cachexia on Immune Checkpoint Inhibitors in Patients With Advanced NSCLC
por: Miyawaki, Taichi, et al.
Publicado: (2020)

The Strategies and Mechanisms of Immune Checkpoint Inhibitors for Brain Metastases in NSCLC
por: Li, Ji, et al.
Publicado: (2022)

A Systematic Review and Meta-Analysis on the Efficacy of Locally Delivered Adjunctive Curcumin (Curcuma longa L.) in the Treatment of Periodontitis
por: Wendorff-Tobolla, Louisa M., et al.
Publicado: (2023)

Efficacy and Safety Analysis of Immune Checkpoint Inhibitors plus Angiogenesis Inhibitors for the Treatment of Advanced Driver-negative NSCLC in Elderly Patients: A Retrospective Study
por: Zhang, Jian, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a Fluke
por: Belluomini, Lorenzo, et al.
Publicado: (2019)

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?
por: Passiglia, Francesco, et al.
Publicado: (2021)

Combining STAT3-Targeting Agents with Immune Checkpoint Inhibitors in NSCLC
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Immune Checkpoint Inhibitors in “Special” NSCLC Populations: A Viable Approach?
por: Bronte, Giuseppe, et al.
Publicado: (2023)

Biomarkers for Immune Checkpoint Inhibitor Response in NSCLC: Current Developments and Applicability
por: Tostes, Katiane, et al.
Publicado: (2023)

Prevalence of mental disorders in young refugees and asylum seekers in European Countries: a systematic review
por: Kien, Christina, et al.
Publicado: (2018)

Monitoring tumor growth rate to predict immune checkpoint inhibitors’ treatment outcome in advanced NSCLC
por: Dall’Olio, Filippo G., et al.
Publicado: (2022)

Reduced FEV(1) as Prognostic Factors in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors
por: Shen, Yi-Luen, et al.
Publicado: (2022)

Trading certainty for speed - how much uncertainty are decisionmakers and guideline developers willing to accept when using rapid reviews: an international survey
por: Wagner, Gernot, et al.
Publicado: (2017)

Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs)
por: Giustini, Nicholas, et al.
Publicado: (2021)

Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications
por: Del Conte, Alessandro, et al.
Publicado: (2022)

Predictive value of CD73 expression for the efficacy of immune checkpoint inhibitors in NSCLC
por: Ishii, Hidenobu, et al.
Publicado: (2020)

Circulating Tumor Cells and Metabolic Parameters in NSCLC Patients Treated with Checkpoint Inhibitors
por: Castello, Angelo, et al.
Publicado: (2020)

SETBP1 mutation determines sensitivity to immune checkpoint inhibitors in melanoma and NSCLC
por: An, Fengxiao, et al.
Publicado: (2023)

Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC
por: Signorelli, Diego, et al.
Publicado: (2022)

Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC
por: De Marchi, Pedro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ehqj83pd8035sh1k90218vj1qt